What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
William T. Creasman focuses on Carcinoma, Internal medicine, Gynecology, Oncology and Gynecologic oncology.
His research in Carcinoma intersects with topics in Corpus Uteri, Cervix, Radiology and Neoplasm Invasiveness.
William T. Creasman combines subjects such as Cancer, Cervical cancer and Adenocarcinoma with his study of Gynecology.
His Oncology research includes elements of Proportional hazards model and Chemotherapy.
His study with Gynecologic oncology involves better knowledge in Surgery.
His Ovarian cancer study combines topics from a wide range of disciplines, such as Endometrial cancer, General surgery and Estrogen.
His most cited work include:
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study (1083 citations)
- Carcinoma of the ovary. (1028 citations)
- American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection (723 citations)
What are the main themes of his work throughout his whole career to date?
William T. Creasman mainly focuses on Internal medicine, Oncology, Carcinoma, Surgery and Gynecologic oncology.
His Oncology research is multidisciplinary, incorporating perspectives in Disease, Proportional hazards model, Stage, Breast cancer and Adenocarcinoma.
His Carcinoma research is multidisciplinary, relying on both Vagina, Gynecology, Neoplasm Invasiveness and Cervix.
His biological study spans a wide range of topics, including Neoplasm staging and Obstetrics.
His Surgery research integrates issues from Cervical cancer and Adverse effect.
His research on Gynecologic oncology also deals with topics like
- Gastroenterology that connect with fields like Leukopenia,
- Randomized controlled trial which is related to area like Clinical trial.
He most often published in these fields:
- Internal medicine (48.65%)
- Oncology (37.30%)
- Carcinoma (29.19%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (48.65%)
- Oncology (37.30%)
- Gynecologic oncology (25.95%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Oncology, Gynecologic oncology, Endometrial cancer and Cervical cancer.
Internal medicine is often connected to Genetic admixture in his work.
His Oncology research also works with subjects such as
- Carcinoma most often made with reference to Confidence interval,
- Adjuvant therapy which connect with Stage ii, Uterine carcinoma and Prospective cohort study.
His Gynecologic oncology study incorporates themes from Survival rate, Group study, Disease, Hazard ratio and Radiation therapy.
Endometrial cancer is the subject of his research, which falls under Cancer.
The Cervical cancer study combines topics in areas such as Surgery, Chemotherapy, Brachytherapy and General surgery.
Between 2015 and 2021, his most popular works were:
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) (158 citations)
- An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer (38 citations)
- Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Endometrial cancer, Oncology, Gynecologic oncology and Disease.
His research in the fields of Group study, Carcinosarcoma, Interim analysis and Neoplasm staging overlaps with other disciplines such as Genotype.
His Carcinosarcoma research is classified as research in Carcinoma.
His Endometrial cancer research incorporates elements of Immunohistochemistry and MLH1, Lynch syndrome, DNA mismatch repair.
His Oncology research incorporates themes from Molecular classification and Medical record.
William T. Creasman interconnects Endometrioid adenocarcinoma, Endometrial Endometrioid Adenocarcinoma and Cohort in the investigation of issues within Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
